Manchester, United Kingdom

David John Evans

This inventor holds 1 USPTO granted patent. Top assignee: Avecia Biologics Limited. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David John Evans. Retrieved from https://idiyas.com/inventor/david-john-evans-4sjr4g3l

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **David John Evans: Innovator in Peptide Synthesis**

Introduction

David John Evans, an accomplished inventor based in Manchester, GB, has made a significant contribution to the field of peptide chemistry. With a singular patent to his name, Evans’ work focuses on the innovative synthesis of peptide amides, showcasing his expertise and dedication to advancing biochemistry.

Latest Patents

Evans holds a patent for a pioneering method entitled “Process for the synthesis of peptides amides by side-chain attachment to a solid phase.” This patented process involves the solid-phase synthesis of a peptide amide, achieved through the attachment of an α-nitrogen protected Cα-carboxamide amino acid to a solid support by its side chain. Following the removal of the α-nitrogen protecting group, a peptide chain is assembled and ultimately cleaved from the solid support. Moreover, this patent includes novel amino acid analogues, peptide amides, and solid-phase supports, highlighting Evans’ innovative approach in the domain of peptide synthesis.

Career Highlights

Throughout his career, David John Evans has worked at Avecia Biologics Limited, a company recognized for its contributions to biologics development and manufacturing. His work with the company has allowed him to apply his knowledge and skills in a practical setting, leading to advancements in peptide synthesis technology.

Collaborations

During his tenure at Avecia Biologics Limited, Evans has collaborated with notable colleagues, including Dean Steven Anthony Simpkin and Donald Alfred Wellings. These collaborations have fostered a creative environment where innovative ideas can flourish, ultimately contributing to the successful development of biotechnological solutions.

Conclusion

David John Evans represents a vital force in the field of peptide synthesis. Through his innovative patented methods and valuable collaborations, he continues to play a crucial role in advancing biochemistry and biotechnology. His work not only enhances our understanding of peptide amides but also paves the way for future innovations in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…